Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 126.04 USD 0.01%
Market Cap: 7.2B USD
Have any thoughts about
Ascendis Pharma A/S?
Write Note

Ascendis Pharma A/S
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ascendis Pharma A/S
PP&E Net Peer Comparison

Comparables:
GMAB
ZEAL
B
BAVA
F
FLUO
BIOPOR

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Ascendis Pharma A/S
NASDAQ:ASND
PP&E Net
€104m
CAGR 3-Years
-6%
CAGR 5-Years
20%
CAGR 10-Years
48%
Genmab A/S
CSE:GMAB
PP&E Net
kr1.9B
CAGR 3-Years
27%
CAGR 5-Years
39%
CAGR 10-Years
55%
Zealand Pharma A/S
CSE:ZEAL
PP&E Net
kr128.9m
CAGR 3-Years
-16%
CAGR 5-Years
6%
CAGR 10-Years
21%
B
Bavarian Nordic A/S
CSE:BAVA
PP&E Net
kr2.4B
CAGR 3-Years
24%
CAGR 5-Years
25%
CAGR 10-Years
22%
F
Fluoguide AS
STO:FLUO
PP&E Net
kr824k
CAGR 3-Years
57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
PP&E Net
kr1.1m
CAGR 3-Years
-54%
CAGR 5-Years
-27%
CAGR 10-Years
4%

See Also

What is Ascendis Pharma A/S's PP&E Net?
PP&E Net
104m EUR

Based on the financial report for Jun 30, 2024, Ascendis Pharma A/S's PP&E Net amounts to 104m EUR.

What is Ascendis Pharma A/S's PP&E Net growth rate?
PP&E Net CAGR 10Y
48%

Over the last year, the PP&E Net growth was -17%. The average annual PP&E Net growth rates for Ascendis Pharma A/S have been -6% over the past three years , 20% over the past five years , and 48% over the past ten years .

Back to Top